References
- Abnet CC, Arnold M, Wei WQ Epidemiology of esophageal squamous cell carcinoma. Gastroenterology 2018; 154:360–373.
- Chen W, Zheng R, Baade PD Cancer statistics in China, 2015. CA Cancer J Clin 2016; 66: 115–132.
- Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med 2003; 349:2241–2252.
- He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004; 5(7):522–531.
- Calin GA, Croce CM.MicroRNA signatures in human cancers. Nat Rev Cancer. 2006; 6:857–866.
- Jia Y, Lu H, Wang C, et al. miR-25 is upregulated before the occurrence of esophageal squamous cell carcinoma. Am J Transl Res 2017;9:4458–4469.
- Wang M, Yang YO, Jin Q, et al. Function of miR-25 in the invasion and metastasis of esophageal squamous carcinoma cells and bioinformatical analysis of the miR-106b-25 cluster. Exp Ther Med 2018;15:440–446.
- Xu X, Chen Z, Zhao X, et al. MicroRNA-25 promotes cell migration and invasion in esophageal squamous cell carcinoma.Biochem Biophys Res Commun 2012;421(4):640–645.
- Lu W, Kang Y Epithelial- mesenchymal plasticity in cancer progression and metastasis. Dev Cell 2019;49:361–374.
- Gloushankova NA, Zhitnyak IY, Rubtsova SN Role of epithelial-mesenchymal transition in tumor progression.Biochem (Mosc) 2018;83:1469–1476.
- Dong P, Ihira K, Xiong Y, et al. Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression. Oncotarget. 2016;7(15):20260–20270
- Tang Q, Zhong H, Xie F, et al. Expression of miR-106b-25 induced by salvianolic acid B inhibits epithelial-to-mesenchymal transition in HK-2 cells. Eur J Pharmacol. 2014;741:97–103.
- Song J, Li Y miR-25-3p reverses epithelial-mesenchymal transition via targeting Sema4C in cisplatin-resistance cervical cancer cells. Cancer Sci. 2017;108(1):23–31.
- Wu C, Wang C, Guan X, et al. Diagnostic and prognostic implications of a serum miRNA panel in oesophageal squamous cell carcinoma. PLoS One. 2014;9:e92292.
- Riihimäki M, Thomsen H, Hemminki A, et al.: Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancer. BMC Cancer 2013; 13:36.
- Pecina-Slaus N, Cicvara-Pecina T, Kafka A: Epithelial-to-mesenchymal transition: possible role in meningiomas. Front Biosci (Elite Ed) 2012; 4:889–896.
- Guarino M, Rubino B, Ballabio G: The role of epithelial-mesenchymal transition in cancer pathology. Pathology 2007; 39:305–318.
- Cavallaro U, Christofori G. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer. 2014;4(2):118–132.
- Karatzas G, Karayiannakis AJ, Syrigos KN, et al. E-cadherin expression correlates with tumor differentiation in colorectal cancer. Hepatogastroenterology. 1999 Jan-Feb;46(25):232–235.
- Syrigos KN, Krausz T, Waxman J, et al. E-cadherin expression in bladder cancer using formalin-fixed, paraffin-embedded tissues: correlation with histopathological grade, tumour stage and survival. Int J Cancer. 1995;64(6):367–370.
- Maretzky T, Reiss K, Ludwig A, et al. ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation. Proc Natl Acad Sci U S A. 2015;102(26):9182–9187.